4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 3.200
-0.590 (-15.57%)
Jul 17, 2026, 4:13 PM AEST
4DMedical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, 4DMedical stock has a consensus rating of "Hold" and an average price target of $4.97. The average 1-year stock price forecast is 55.31% higher than the current stock price, while the lowest is $3.00 (-6.25%) and the highest is $6.00 (+87.50%).
Price Target: $4.97 (+55.31%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Jun 3, 2026.
Analyst Ratings
The average analyst rating for 4DMedical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ord Minnett | Ord Minnett | Sell Maintains $3.00 | Sell | Maintains | $3.00 | -6.25% | Jun 3, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $6.00 | Buy | Maintains | $6.00 | +87.50% | Jun 2, 2026 |
| Jefferies | Jefferies | Hold Downgrades $5.90 | Hold | Downgrades | $5.90 | +84.38% | Apr 23, 2026 |
Financial Forecast
Revenue This Year
8.34M
from 5.85M
Increased by 42.48%
Revenue Next Year
22.25M
from 8.34M
Increased by 166.83%
EPS This Year
-0.08
from -0.14
EPS Next Year
-0.06
from -0.08
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.